marketcaparena

EMBC

Embecta Corp.

Company overview

Market capitalization
$335.99M
Employees
1,850
Latest publication
2026-09-29
About Embecta Corp.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
Total Revenue271,700,000USD221,800,000USD261,200,000USD264,000,000USD295,500,000USD259,000,000USD261,900,000USD286,100,000USD
Cost Of Revenue118,400,000USD96,600,000USD85,600,000USD108,000,000USD100,500,000USD97,500,000USD95,000,000USD114,800,000USD
Gross Profit153,300,000USD125,200,000USD175,600,000USD156,000,000USD195,000,000USD161,500,000USD166,900,000USD171,300,000USD
Research Development5,600,000USD9,700,000USD300,000USD4,600,000USD3,800,000USD3,700,000USD9,500,000USD19,800,000USD
Selling General Administrative78,600,000USD76,200,000USD77,600,000USD86,900,000USD84,400,000USD79,600,000USD81,100,000USD87,800,000USD
Total Operating Expenses104,600,000USD82,300,000USD78,500,000USD91,600,000USD88,900,000USD83,000,000USD90,000,000USD137,700,000USD
Operating Income48,700,000USD42,900,000USD97,100,000USD64,400,000USD106,100,000USD78,500,000USD76,900,000USD33,600,000USD
Total Other Income Expense Net-21,100,000USD-33,400,000USD-38,200,000USD-35,400,000USD-33,900,000USD-42,700,000USD-77,600,000USD-40,600,000USD
Income Before Tax27,600,000USD9,500,000USD58,900,000USD29,000,000USD72,200,000USD35,800,000USD-700,000USD-7,000,000USD
Income Tax Expense6,500,000USD13,600,000USD14,800,000USD2,600,000USD26,700,000USD12,300,000USD-700,000USD-21,600,000USD
Net Income21,100,000USD-4,100,000USD44,100,000USD26,400,000USD45,500,000USD23,500,000USD-700,000USD14,600,000USD
Unclassified Operating Expenses—-3,600,000USD—————21,100,000USD
Interest Expense—22,600,000USD24,100,000USD26,100,000USD26,600,000USD26,700,000USD27,900,000USD29,000,000USD
Net Interest Income—-22,600,000USD-24,100,000USD-26,100,000USD-26,600,000USD-26,700,000USD-27,900,000USD-29,000,000USD
Tax Provision—13,600,000USD14,800,000USD2,600,000USD26,700,000USD12,300,000USD-700,000USD-21,600,000USD
Net Income From Continuing Ops—-4,100,000USD44,100,000USD26,400,000USD45,500,000USD23,500,000USD0USD14,600,000USD
Ebit—42,900,000USD83,000,000USD55,100,000USD98,800,000USD62,500,000USD27,200,000USD22,000,000USD
Ebitda—55,700,000USD95,900,000USD70,800,000USD110,600,000USD74,200,000USD39,100,000USD34,000,000USD
Depreciation And Amortization—12,800,000USD12,900,000USD15,700,000USD11,800,000USD11,700,000USD11,900,000USD12,000,000USD
Reconciled Depreciation—12,800,000USD12,900,000USD5,300,000USD11,800,000USD11,700,000USD11,900,000USD5,700,000USD
Selling And Marketing Expenses———————9,000,000USD
Source0001872789-26-000033DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USD
Total Revenue1,080,400,000USD1,123,100,000USD1,120,800,000USD1,129,500,000USD1,165,000,000USD1,085,500,000USD1,109,000,000USD
Cost Of Revenue400,900,000USD394,200,000USD370,900,000USD354,600,000USD365,000,000USD323,000,000USD323,000,000USD
Gross Profit679,500,000USD728,900,000USD749,900,000USD774,900,000USD800,000,000USD763,000,000USD786,000,000USD
Research Development21,500,000USD78,800,000USD85,200,000USD65,000,000USD63,000,000USD61,000,000USD62,000,000USD
Selling General Administrative318,000,000USD356,100,000USD325,800,000USD283,200,000USD300,000USD300,000USD222,000,000USD
Unclassified Operating Expenses10,700,000USD110,800,000USD93,799,999USD37,000,000USD4,700,000USD——
Total Operating Expenses350,200,000USD554,700,000USD520,299,999USD396,800,000USD308,000,000USD276,000,000USD284,000,000USD
Operating Income329,300,000USD174,200,000USD229,600,000USD378,100,000USD492,000,000USD487,000,000USD502,000,000USD
Interest Expense107,300,000USD112,300,000USD107,000,000USD46,200,000USD3,000,000USD0USD2,000,000USD
Net Interest Income-107,300,000USD-112,300,000USD-107,000,000USD-46,200,000USD0USD0USD—
Income Before Tax136,300,000USD44,200,000USD105,700,000USD256,600,000USD495,000,000USD485,800,000USD500,000,000USD
Income Tax Expense40,900,000USD-34,100,000USD35,300,000USD33,000,000USD80,000,000USD58,200,000USD68,000,000USD
Tax Provision40,900,000USD-34,100,000USD35,300,000USD33,000,000USD80,000,000USD58,000,000USD68,000,000USD
Net Income95,400,000USD78,300,000USD70,400,000USD223,600,000USD414,800,000USD427,600,000USD432,000,000USD
Net Income From Continuing Ops95,400,000USD78,300,000USD70,400,000USD223,600,000USD415,000,000USD428,000,000USD432,000,000USD
Ebit243,600,000USD156,500,000USD212,700,000USD302,800,000USD495,000,000USD486,000,000USD500,000,000USD
Ebitda294,700,000USD199,000,000USD245,400,000USD334,500,000USD533,000,000USD524,000,000USD536,000,000USD
Depreciation And Amortization51,100,000USD42,500,000USD32,700,000USD31,700,000USD38,000,000USD38,000,000USD36,000,000USD
Reconciled Depreciation40,700,000USD36,200,000USD32,600,000USD31,700,000USD38,000,000USD38,000,000USD36,000,000USD
Total Other Income Expense Net-193,000,000USD-130,000,000USD-123,900,000USD-121,499,999USD3,000,000USD-1,000,000USD-2,000,000USD
Selling And Marketing Expenses—9,000,000USD15,500,000USD11,600,000USD240,000,000USD215,000,000USD—
Non Operating Income Net Other———-6,800,000USD———
Net Income Applicable To Common Shares———223,600,000USD415,000,000USD428,000,000USD432,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
Total Assets1,265,300,000USD1,029,300,000USD1,063,700,000USD1,090,900,000USD1,157,300,000USD1,120,200,000USD1,149,500,000USD1,285,300,000USD
Cash And Equivalents214,700,000USD———————
Total Current Assets705,100,000USD608,100,000USD620,200,000USD631,400,000USD681,500,000USD643,400,000USD667,200,000USD761,000,000USD
Other Current Assets90,500,000USD83,500,000USD74,800,000USD78,400,000USD78,200,000USD62,300,000USD67,600,000USD74,000,000USD
Total Liabilities1,878,000,000USD———————
Total Current Liabilities419,800,000USD247,300,000USD234,700,000USD261,500,000USD275,500,000USD259,300,000USD298,200,000USD374,000,000USD
Other Current Liabilities138,600,000USD———————
Total Stockholder Equity-612,700,000USD-626,100,000USD-613,100,000USD-650,600,000USD-669,600,000USD-736,200,000USD-768,800,000USD-738,300,000USD
Total Equity Including Noncontrolling Interest-612,700,000USD———————
Short Long Term Debt139,400,000USD9,500,000USD9,500,000USD9,500,000USD9,500,000USD9,500,000USD9,500,000USD9,500,000USD
Long Term Debt1,315,700,000USD1,316,900,000USD1,352,900,000USD1,388,700,000USD1,458,800,000USD1,509,100,000USD1,534,700,000USD1,565,300,000USD
Net Receivables182,200,000USD147,100,000USD159,200,000USD148,900,000USD182,800,000USD202,600,000USD220,500,000USD248,000,000USD
Inventory214,200,000USD192,600,000USD181,800,000USD178,600,000USD189,900,000USD169,200,000USD169,100,000USD171,500,000USD
Property Plant Equipment Net335,000,000USD237,500,000USD248,900,000USD257,200,000USD262,700,000USD257,400,000USD258,899,999USD290,400,000USD
Goodwill39,900,000USD———————
Intangible Assets47,500,000USD6,500,000USD6,700,000USD7,000,000USD7,300,000USD7,600,000USD7,900,000USD8,100,000USD
Accounts Payable90,500,000USD79,700,000USD72,100,000USD74,200,000USD61,900,000USD58,800,000USD73,000,000USD91,000,000USD
Short Term Debt6,400,000USD13,000,000USD13,000,000USD16,300,000USD12,900,000USD12,900,000USD12,900,000USD12,900,000USD
Common Stock600,000USD600,000USD600,000USD600,000USD600,000USD600,000USD600,000USD600,000USD
Retained Earnings-404,300,000USD-424,700,000USD-411,100,000USD-445,600,000USD-457,100,000USD-493,500,000USD-507,900,000USD-498,600,000USD
Accumulated Other Comprehensive Income-292,600,000USD-290,000,000USD-284,400,000USD-285,600,000USD-283,300,000USD-308,300,000USD-319,700,000USD-292,800,000USD
Total Liab—1,655,400,000USD1,676,800,000USD1,741,500,000USD1,826,900,000USD1,856,400,000USD1,918,300,000USD2,023,600,000USD
Other Current Liab—148,400,000USD142,900,000USD161,200,000USD193,600,000USD187,600,000USD212,300,000USD432,000,000USD
Capital Stock—600,000USD600,000USD0USD600,000USD600,000USD600,000USD600,000USD
Good Will—21,900,000USD15,400,000USD15,400,000USD15,400,000USD15,500,000USD15,500,000USD15,600,000USD
Cash—184,900,000USD204,400,000USD225,500,000USD230,600,000USD209,300,000USD210,000,000USD267,500,000USD
Cash And Short Term Investments—184,900,000USD204,400,000USD225,500,000USD230,600,000USD209,300,000USD210,000,000USD267,500,000USD
Net Debt—1,172,800,000USD1,215,400,000USD1,204,800,000USD1,270,200,000USD1,342,200,000USD1,367,400,000USD1,340,900,000USD
Short Long Term Debt Total—1,357,700,000USD1,419,800,000USD1,430,300,000USD1,500,800,000USD1,551,500,000USD1,577,400,000USD1,608,400,000USD
Property Plant Equipment Gross—752,300,000USD786,500,000USD791,300,000USD789,000,000USD754,000,000USD735,600,000USD779,100,000USD
Common Stock Shares Outstanding—58,915,000shares58,915,000shares58,867,000shares58,495,000shares58,622,000shares58,622,000shares58,084,000shares
Non Current Assets Total—421,200,000USD443,500,000USD459,500,000USD475,800,000USD476,800,000USD482,300,000USD524,300,000USD
Non Current Liabilities Total—1,408,100,000USD1,442,100,000USD1,480,000,000USD1,551,400,000USD1,597,100,000USD1,620,100,000USD1,649,600,000USD
Non Current Liabilities Other—63,400,000USD61,000,000USD63,200,000USD63,500,000USD58,500,000USD55,600,000USD54,100,000USD
Non Currrent Assets Other—161,800,000USD172,500,000USD179,900,000USD190,400,000USD196,300,000USD200,000,000USD210,200,000USD
Net Working Capital—360,800,000USD385,500,000USD369,900,000USD406,000,000USD384,100,000USD369,000,000USD387,000,000USD
Unclassified Non Current Assets—-6,500,000USD——————
Unclassified Current Liabilities—-3,300,000USD-2,800,000USD——-9,500,000USD-9,500,000USD-171,400,000USD
Unclassified Non Current Liabilities—27,800,000USD28,200,000USD28,100,000USD29,100,000USD29,500,000USD29,800,000USD30,200,000USD
Unclassified Equity—87,400,000USD81,200,000USD80,000,000USD69,600,000USD64,400,000USD57,600,000USD51,900,000USD
Current Deferred Revenue———————-188,600,000USD
Source0001872789-26-000033DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USD
Total Assets1,090,900,000USD1,285,300,000USD1,214,400,000USD1,086,400,000USD788,000,000USD738,000,000USD745,000,000USD
Intangible Assets7,000,000USD8,100,000USD9,100,000USD8,900,000USD18,000,000USD14,000,000USD16,000,000USD
Other Current Assets78,400,000USD74,000,000USD252,600,000USD187,600,000USD23,400,000USD13,000,000USD20,000,000USD
Total Liab1,742,100,000USD2,023,600,000USD2,036,100,000USD1,977,800,000USD194,000,000USD166,000,000USD126,000,000USD
Total Stockholder Equity-650,600,000USD-738,300,000USD-821,700,000USD-891,400,000USD594,000,000USD572,000,000USD577,000,000USD
Other Current Liab174,400,000USD243,400,000USD213,800,000USD219,300,000USD109,800,000USD87,000,000USD79,000,000USD
Common Stock600,000USD600,000USD600,000USD600,000USD865,000,000USD834,000,000USD855,000,000USD
Capital Stock0USD600,000USD600,000USD600,000USD865,000,000USD834,000,000USD—
Retained Earnings-445,600,000USD-498,600,000USD-541,100,000USD-577,100,000USD0USD——
Good Will15,400,000USD15,600,000USD15,600,000USD15,700,000USD16,000,000USD16,000,000USD16,000,000USD
Cash225,500,000USD267,500,000USD326,300,000USD330,900,000USD0USD——
Cash And Short Term Investments225,500,000USD267,500,000USD326,500,000USD330,900,000USD———
Total Current Assets631,400,000USD761,000,000USD749,100,000USD664,700,000USD292,000,000USD235,000,000USD248,000,000USD
Total Current Liabilities261,500,000USD374,000,000USD353,500,000USD301,000,000USD164,000,000USD137,000,000USD126,000,000USD
Net Debt1,204,800,000USD1,340,900,000USD1,312,000,000USD1,312,900,000USD4,000,000USD5,000,000USD—
Short Term Debt12,900,000USD12,900,000USD19,000,000USD13,100,000USD1,000,000USD1,000,000USD—
Short Long Term Debt9,500,000USD9,500,000USD9,500,000USD9,500,000USD———
Short Long Term Debt Total1,430,300,000USD1,608,400,000USD1,638,500,000USD1,643,800,000USD4,000,000USD5,000,000USD—
Long Term Debt1,388,700,000USD1,565,300,000USD1,593,900,000USD1,598,100,000USD———
Net Receivables148,900,000USD248,000,000USD17,900,000USD23,400,000USD150,600,000USD120,000,000USD127,000,000USD
Inventory178,600,000USD171,500,000USD152,100,000USD122,800,000USD118,000,000USD102,000,000USD101,000,000USD
Accounts Payable74,200,000USD91,000,000USD53,500,000USD41,400,000USD54,200,000USD50,000,000USD47,000,000USD
Property Plant Equipment Net48,500,000USD290,400,000USD323,200,000USD301,600,000USD451,000,000USD462,000,000USD457,000,000USD
Property Plant Equipment Gross791,300,000USD779,100,000USD747,900,000USD701,600,000USD892,000,000USD891,000,000USD—
Accumulated Other Comprehensive Income-285,600,000USD-292,800,000USD-309,100,000USD-324,900,000USD-271,000,000USD-262,000,000USD-278,000,000USD
Common Stock Shares Outstanding58,915,000shares58,326,000shares57,758,000shares57,055,327shares56,804,716shares57,000,000shares57,000,000shares
Non Current Assets Total459,500,000USD524,300,000USD465,300,000USD421,700,000USD496,000,000USD503,000,000USD497,000,000USD
Non Current Liabilities Total1,480,000,000USD1,649,600,000USD1,682,600,000USD1,676,800,000USD29,700,000USD29,000,000USD—
Non Current Liabilities Other63,200,000USD54,100,000USD57,200,000USD46,100,000USD30,000,000USD29,000,000USD—
Non Currrent Assets Other368,400,000USD210,200,000USD117,400,000USD95,500,000USD11,000,000USD11,000,000USD8,000,000USD
Net Working Capital369,900,000USD387,000,000USD395,600,000USD363,700,000USD128,000,000USD98,000,000USD—
Unclassified Non Current Assets20,200,000USD——-89,200,000USD-7,000,000USD-6,000,000USD-8,000,000USD
Unclassified Current Liabilities-9,500,000USD17,200,000USD24,100,000USD17,700,000USD———
Unclassified Non Current Liabilities28,100,000USD30,200,000USD31,500,000USD-55,300,000USD-27,300,000USD-25,000,000USD—
Unclassified Equity80,000,000USD51,900,000USD27,300,000USD9,400,000USD-865,000,000USD-834,000,000USD—
Current Deferred Revenue——33,600,000USD—-1,000,000USD-1,000,000USD—
Deferred Long Term Liab———46,100,000USD———
Other Liab———41,800,000USD27,000,000USD25,000,000USD42,000,000USD
Other Assets———89,200,000USD7,000,000USD6,000,000USD8,000,000USD
Net Tangible Assets———-883,400,000USD560,000,000USD542,000,000USD545,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20262026-06-30 · USD
Depreciation31,100,000USD
Stock Based Compensation15,800,000USD
Deferred Income Tax12,100,000USD
Change To Account Receivables-20,800,000USD
Change To Inventory-7,300,000USD
Change To Liabilities1,100,000USD
Change In Working Capital-33,100,000USD
Operating Cash Flow90,100,000USD
Capital Expenditures-2,200,000USD
Other Investing Activities-118,300,000USD
Investing Cash Flow-120,500,000USD
Net Debt Issuance-78,600,000USD
Net Common Stock Issuance-13,600,000USD
Common Dividends Paid-18,400,000USD
Unclassified Financing Cash Flow129,900,000USD
Financing Cash Flow19,300,000USD
Effect Of Forex Changes On Cash700,000USD
Change In Cash-10,400,000USD
End Cash Flow218,200,000USD
Source0001872789-26-000033DeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
Net Income-4,099,999USD44,100,000USD26,400,000USD45,500,000USD23,500,000USD-26,300,000USD14,600,000USD14,700,000USD
Depreciation12,800,000USD10,300,000USD15,700,000USD11,800,000USD6,500,000USD11,900,000USD5,700,000USD11,100,000USD
Stock Based Compensation5,700,000USD5,900,000USD9,500,000USD5,900,000USD7,300,000USD8,900,000USD6,200,000USD6,300,000USD
Other Non Cash Items8,099,999USD-5,600,000USD12,100,000USD2,600,000USD7,200,000USD12,500,000USD8,400,000USD1,600,000USD
Change To Account Receivables11,300,000USD-12,000,000USD32,500,000USD8,000,000USD-2,100,000USD5,800,000USD-18,500,000USD-49,500,000USD
Change To Inventory-13,900,000USD-3,500,000USD5,200,000USD-9,300,000USD2,500,000USD-4,500,000USD16,300,000USD-34,800,000USD
Change In Working Capital7,900,000USD-40,900,000USD24,100,000USD9,100,000USD-16,000,000USD-40,900,000USD19,400,000USD-32,500,000USD
Total Cash From Operating Activities31,100,000USD17,200,000USD84,000,000USD81,200,000USD31,800,000USD-5,300,000USD26,600,000USD-2,100,000USD
Capital Expenditures-500,000USD-600,000USD-7,300,000USD-400,000USD-100,000USD-1,500,000USD0USD-9,700,000USD
Free Cash Flow30,600,000USD16,600,000USD76,700,000USD80,800,000USD31,700,000USD-6,800,000USD26,600,000USD-11,800,000USD
Total Cashflows From Investing Activities-500,000USD9,500,000USD-7,300,000USD-400,000USD-100,000USD-1,500,000USD—-9,700,000USD
Net Borrowings-37,900,000USD-37,900,000USD-72,800,000USD-52,800,000USD-27,700,000USD-32,700,000USD-27,700,000USD—
Total Cash From Financing Activities-41,500,000USD-51,600,000USD-81,600,000USD-62,600,000USD-37,300,000USD-45,200,000USD-36,600,000USD-11,500,000USD
Dividends Paid-8,900,000USD-8,900,000USD-8,800,000USD-8,700,000USD-8,700,000USD-8,800,000USD-8,700,000USD-8,600,000USD
Change In Cash-11,000,000USD-24,200,000USD-5,000,000USD21,300,000USD-4,400,000USD-57,500,000USD-7,600,000USD-24,700,000USD
Begin Period Cash Flow204,400,000USD228,600,000USD233,600,000USD212,300,000USD216,700,000USD274,200,000USD281,800,000USD306,500,000USD
End Period Cash Flow193,400,000USD204,400,000USD228,600,000USD233,600,000USD212,300,000USD216,700,000USD274,200,000USD281,800,000USD
Other Cashflows From Financing Activities5,300,000USD—-5,700,000USD-1,100,000USD-28,300,000USD-3,700,000USD-200,000USD-100,000USD
Sale Purchase Of Stock—-4,800,000USD5,700,000USD-1,100,000USD-900,000USD-3,700,000USD-200,000USD-100,000USD
Other Cashflows From Investing Activities—10,100,000USD——————
Unclassified Operating Cash Flow—3,400,000USD-3,800,000USD6,300,000USD3,300,000USD28,600,000USD-27,700,000USD-3,300,000USD
Investments——-7,300,000USD-400,000USD-100,000USD-1,500,000USD0USD-9,700,000USD
Unclassified Investing Cash Flow——7,300,000USD——1,500,000USD—9,700,000USD
Unclassified Financing Cash Flow———1,100,000USD28,300,000USD3,700,000USD—-2,700,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USD
Net Income95,400,000USD78,300,000USD70,400,000USD223,600,000USD415,000,000USD427,600,000USD432,000,000USD
Depreciation40,700,000USD36,200,000USD32,600,000USD31,700,000USD38,000,000USD38,300,000USD36,000,000USD
Stock Based Compensation31,600,000USD26,300,000USD21,500,000USD18,700,000USD12,800,000USD12,700,000USD12,000,000USD
Other Non Cash Items30,100,000USD13,200,000USD8,900,000USD72,300,000USD24,200,000USD9,400,000USD9,000,000USD
Change To Account Receivables44,200,000USD-174,700,000USD7,000,000USD122,700,000USD-32,000,000USD-2,400,000USD-10,000,000USD
Change To Inventory-6,100,000USD-16,500,000USD-28,800,000USD-23,400,000USD-18,000,000USD3,500,000USD9,000,000USD
Change In Working Capital-23,700,000USD-47,700,000USD-80,000,000USD92,400,000USD-32,000,000USD12,700,000USD22,000,000USD
Total Cash From Operating Activities191,700,000USD35,700,000USD67,700,000USD412,200,000USD456,000,000USD498,500,000USD505,000,000USD
Capital Expenditures-9,300,000USD-15,800,000USD-26,500,000USD-24,000,000USD-39,000,000USD-41,900,000USD-69,000,000USD
Free Cash Flow182,400,000USD19,900,000USD41,200,000USD388,200,000USD417,000,000USD456,600,000USD436,000,000USD
Investments-9,300,000USD-15,800,000USD-26,500,000USD-24,000,000USD-39,000,000USD-42,000,000USD-69,000,000USD
Total Cashflows From Investing Activities-9,300,000USD-15,800,000USD-26,500,000USD-24,000,000USD-39,000,000USD-41,900,000USD-69,000,000USD
Net Borrowings-186,000,000USD-35,900,000USD-10,700,000USD1,411,900,000USD1,443,400,000USD1,443,400,000USD1,443,400,000USD
Total Cash From Financing Activities-226,700,000USD-73,400,000USD-48,700,000USD-48,000,000USD-417,000,000USD-456,600,000USD-436,000,000USD
Dividends Paid-35,000,000USD-34,500,000USD-34,400,000USD-8,600,000USD-8,600,000USD-8,600,000USD-8,600,000USD
Sale Purchase Of Stock-5,700,000USD-3,000,000USD-3,600,000USD————
Change In Cash-45,600,000USD-52,300,000USD-4,400,000USD330,900,000USD-417,000,000USD-457,000,000USD-436,000,000USD
Begin Period Cash Flow274,200,000USD326,500,000USD330,900,000USD264,300,000USD0USD0USD0USD
End Period Cash Flow228,600,000USD274,200,000USD326,500,000USD330,900,000USD264,300,000USD0USD0USD
Other Cashflows From Financing Activities-5,700,000USD-3,000,000USD-3,600,000USD-32,800,000USD-417,000,000USD-456,600,000USD-436,000,000USD
Unclassified Operating Cash Flow17,600,000USD-70,600,000USD14,300,000USD-26,500,000USD——-6,000,000USD
Unclassified Investing Cash Flow9,300,000USD15,800,000USD26,500,000USD24,400,000USD41,400,000USD42,000,000USD72,000,000USD
Unclassified Financing Cash Flow5,700,000USD3,000,000USD3,600,000USD-1,418,500,000USD-1,434,800,000USD-1,434,800,000USD-1,434,800,000USD
Change To Liabilities———83,600,000USD30,000,000USD-4,000,000USD32,000,000USD
Cash And Cash Equivalents Changes———340,200,000USD———
Other Cashflows From Investing Activities———-400,000USD-2,400,000USD—-3,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-03-31GeographyInternational126,400,000USD0001872789-26-000017
Q2 2026Quarterly · 2026-03-31GeographyUnited States95,400,000USD0001872789-26-000017
Q2 2026Quarterly · 2026-03-31ProductManufacturing Facility2,500,000USD0001872789-26-000017
Q2 2026Quarterly · 2026-03-31ProductPen Needles154,700,000USD0001872789-26-000017
Q2 2026Quarterly · 2026-03-31ProductProduct And Service Other4,000,000USD0001872789-26-000017
Q2 2026Quarterly · 2026-03-31ProductSafety34,300,000USD0001872789-26-000017
Q2 2026Quarterly · 2026-03-31ProductSyringes26,300,000USD0001872789-26-000017
Q1 2026Quarterly · 2025-12-31GeographyInternational130,300,000USD0001872789-26-000009
Q1 2026Quarterly · 2025-12-31GeographyUnited States130,900,000USD0001872789-26-000009
Q1 2026Quarterly · 2025-12-31ProductManufacturing Facility4,100,000USD0001872789-26-000009
Q1 2026Quarterly · 2025-12-31ProductPen Needles185,500,000USD0001872789-26-000009
Q1 2026Quarterly · 2025-12-31ProductProduct And Service Other3,600,000USD0001872789-26-000009
Q1 2026Quarterly · 2025-12-31ProductSafety37,300,000USD0001872789-26-000009
Q1 2026Quarterly · 2025-12-31ProductSyringes30,700,000USD0001872789-26-000009
Q4 2025Quarterly · 2025-09-30GeographyInternational122,000,000USDLegacy provider
Q4 2025Quarterly · 2025-09-30GeographyUnited States142,000,000USDLegacy provider
Q4 2025Quarterly · 2025-09-30ProductManufacturing Facility5,200,000USDLegacy provider
Q4 2025Quarterly · 2025-09-30ProductPen Needles187,800,000USDLegacy provider
Q4 2025Quarterly · 2025-09-30ProductProduct And Service Other4,100,000USDLegacy provider
Q4 2025Quarterly · 2025-09-30ProductSafety34,600,000USDLegacy provider
Q4 2025Quarterly · 2025-09-30ProductSyringes32,300,000USDLegacy provider
FY 2025Yearly · 2025-09-30GeographyInternational501,300,000USD0001872789-25-000036
FY 2025Yearly · 2025-09-30GeographyUnited States579,100,000USD0001872789-25-000036
FY 2025Yearly · 2025-09-30ProductManufacturing Facility19,900,000USD0001872789-25-000036
FY 2025Yearly · 2025-09-30ProductPen Needles784,100,000USD0001872789-25-000036
FY 2025Yearly · 2025-09-30ProductProduct And Service Other14,000,000USD0001872789-25-000036
FY 2025Yearly · 2025-09-30ProductSafety137,800,000USD0001872789-25-000036
FY 2025Yearly · 2025-09-30ProductSyringes124,600,000USD0001872789-25-000036
Q3 2025Quarterly · 2025-06-30GeographyInternational135,300,000USD0001872789-25-000029
Q3 2025Quarterly · 2025-06-30GeographyUnited States160,200,000USD0001872789-25-000029
Q3 2025Quarterly · 2025-06-30ProductManufacturing Facility5,500,000USD0001872789-25-000029
Q3 2025Quarterly · 2025-06-30ProductPen Needles216,900,000USD0001872789-25-000029
Q3 2025Quarterly · 2025-06-30ProductProduct And Service Other3,200,000USD0001872789-25-000029
Q3 2025Quarterly · 2025-06-30ProductSafety34,800,000USD0001872789-25-000029
Q3 2025Quarterly · 2025-06-30ProductSyringes35,100,000USD0001872789-25-000029
Q2 2025Quarterly · 2025-03-31GeographyInternational123,800,000USD0001872789-26-000017
Q2 2025Quarterly · 2025-03-31GeographyUnited States135,200,000USD0001872789-26-000017
Q2 2025Quarterly · 2025-03-31ProductManufacturing Facility4,400,000USD0001872789-26-000017
Q2 2025Quarterly · 2025-03-31ProductPen Needles188,300,000USD0001872789-26-000017
Q2 2025Quarterly · 2025-03-31ProductProduct And Service Other3,300,000USD0001872789-26-000017
Q2 2025Quarterly · 2025-03-31ProductSafety34,200,000USD0001872789-26-000017
Q2 2025Quarterly · 2025-03-31ProductSyringes28,800,000USD0001872789-26-000017
Q1 2025Quarterly · 2024-12-31GeographyInternational120,200,000USD0001872789-26-000009
Q1 2025Quarterly · 2024-12-31GeographyUnited States141,700,000USD0001872789-26-000009
Q1 2025Quarterly · 2024-12-31ProductManufacturing Facility4,800,000USD0001872789-26-000009
Q1 2025Quarterly · 2024-12-31ProductPen Needles191,100,000USD0001872789-26-000009
Q1 2025Quarterly · 2024-12-31ProductProduct And Service Other3,400,000USD0001872789-26-000009
Q1 2025Quarterly · 2024-12-31ProductSafety34,200,000USD0001872789-26-000009
Q1 2025Quarterly · 2024-12-31ProductSyringes28,400,000USD0001872789-26-000009
Q4 2024Quarterly · 2024-09-30GeographyInternational118,700,000USDLegacy provider
Q4 2024Quarterly · 2024-09-30GeographyUnited States167,400,000USDLegacy provider
Q4 2024Quarterly · 2024-09-30ProductManufacturing Facility4,700,000USDLegacy provider
Q4 2024Quarterly · 2024-09-30ProductPen Needles215,100,000USDLegacy provider
Q4 2024Quarterly · 2024-09-30ProductProduct And Service Other0USDLegacy provider
Q4 2024Quarterly · 2024-09-30ProductSafety32,900,000USDLegacy provider
Q4 2024Quarterly · 2024-09-30ProductSyringes33,700,000USDLegacy provider
FY 2024Yearly · 2024-09-30GeographyInternational515,900,000USD0001872789-25-000036
FY 2024Yearly · 2024-09-30GeographyUnited States607,200,000USD0001872789-25-000036
FY 2024Yearly · 2024-09-30ProductManufacturing Facility12,800,000USD0001872789-25-000036
FY 2024Yearly · 2024-09-30ProductPen Needles844,400,000USD0001872789-25-000036
FY 2024Yearly · 2024-09-30ProductProduct And Service Other10,300,000USD0001872789-25-000036
FY 2024Yearly · 2024-09-30ProductSafety129,400,000USD0001872789-25-000036
FY 2024Yearly · 2024-09-30ProductSyringes126,200,000USD0001872789-25-000036
Q3 2024Quarterly · 2024-06-30GeographyInternational128,900,000USD0001872789-25-000029
Q3 2024Quarterly · 2024-06-30GeographyUnited States143,600,000USD0001872789-25-000029
Q3 2024Quarterly · 2024-06-30ProductManufacturing Facility3,600,000USD0001872789-25-000029
Q3 2024Quarterly · 2024-06-30ProductPen Needles201,300,000USD0001872789-25-000029
Q3 2024Quarterly · 2024-06-30ProductProduct And Service Other3,500,000USD0001872789-25-000029
Q3 2024Quarterly · 2024-06-30ProductSafety32,400,000USD0001872789-25-000029
Q3 2024Quarterly · 2024-06-30ProductSyringes31,700,000USD0001872789-25-000029
FY 2023Yearly · 2023-09-30GeographyInternational519,400,000USD0001872789-25-000036
FY 2023Yearly · 2023-09-30GeographyUnited States601,400,000USD0001872789-25-000036
FY 2023Yearly · 2023-09-30ProductManufacturing Facility13,000,000USD0001872789-25-000036
FY 2023Yearly · 2023-09-30ProductPen Needles829,200,000USD0001872789-25-000036
FY 2023Yearly · 2023-09-30ProductProduct And Service Other14,200,000USD0001872789-25-000036
FY 2023Yearly · 2023-09-30ProductSafety126,300,000USD0001872789-25-000036
FY 2023Yearly · 2023-09-30ProductSyringes138,100,000USD0001872789-25-000036
FY 2022Yearly · 2022-09-30GeographyInternational529,200,000USD0001872789-24-000037
FY 2022Yearly · 2022-09-30GeographyUnited States600,300,000USD0001872789-24-000037
FY 2022Yearly · 2022-09-30ProductManufacturing Facility15,000,000USD0001872789-24-000037
FY 2022Yearly · 2022-09-30ProductPen Needles824,600,000USD0001872789-24-000037
FY 2022Yearly · 2022-09-30ProductProduct And Service Other14,300,000USD0001872789-24-000037
FY 2022Yearly · 2022-09-30ProductSafety119,600,000USD0001872789-24-000037
FY 2022Yearly · 2022-09-30ProductSyringes156,000,000USD0001872789-24-000037
FY 2021Yearly · 2021-09-30GeographyInternational555,900,000USD0001872789-23-000031
FY 2021Yearly · 2021-09-30GeographyUnited States609,400,000USD0001872789-23-000031
FY 2020Yearly · 2020-09-30GeographyInternational522,500,000USD0001872789-22-000024
FY 2020Yearly · 2020-09-30GeographyUnited States563,000,000USD0001872789-22-000024

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.